Author:
Perks C M,Keith A J,Goodhew K L,Savage P B,Winters Z E,Holly J M P
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Anderson E, Ferguson JE, Morten H, Shalet SM, Robinson EL, Howell A (1993) Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide. Eur J Cancer 29A: 209–217
2. Binart N, Ormandy CJ, Kelly PA (2000) Mammary gland development and the prolactin receptor. Adv Exp Med Biol 480: 85–92
3. Bollengier F, Mahler A, Braet C, Claeyssens M, Vanhaelst L (2001) Glycosylated rat prolactin: isolation and structural characterization. Arch Physiol Biochem 109: 180–190
4. Bonneterre J, Mauriac L, Weber B, Roche H, Fargeot P, Tubiana-Hulin M, Sevin M, Chollet P, Cappelaere P (1988) Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial. Eur J Cancer Clin Oncol 24: 1851–1853
5. Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE (1999) A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res 5: 3583–3593
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献